Increasing access to COVID-19 vaccines requires the creative use of financial tools, according to experts speaking Monday at a Devex event on the future of development finance.
“The time is now for us to invest. The time is now for us to be creative,” said Nafisa Jiwani, managing director of health initiatives at the U.S. International Development Finance Corporation.
This includes efforts to decentralize vaccine manufacturing, she said. The African continent currently imports 99% of its vaccines.